110 related articles for article (PubMed ID: 14506187)
41. A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies.
Brard PY; Karacay H; Stein R; Sharkey RM; Mattes MJ; Chang CH; Rossi EA; McBride WJ; Goldenberg DM
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5564s-5571s. PubMed ID: 17875790
[TBL] [Abstract][Full Text] [Related]
42. Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy.
Janevik-Ivanovska E; Gautherot E; Hillairet de Boisferon M; Cohen M; Milhaud G; Tartar A; Rostene W; Barbet J; Gruaz-Guyon A
Bioconjug Chem; 1997; 8(4):526-33. PubMed ID: 9258451
[TBL] [Abstract][Full Text] [Related]
43. Pretargeted radioimmunotherapy of cancer: progress step by step.
Boerman OC; van Schaijk FG; Oyen WJ; Corstens FH
J Nucl Med; 2003 Mar; 44(3):400-11. PubMed ID: 12621007
[TBL] [Abstract][Full Text] [Related]
44. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
[TBL] [Abstract][Full Text] [Related]
45. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
[TBL] [Abstract][Full Text] [Related]
46. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
47. Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
Kraeber-Bodéré F; Rousseau C; Bodet-Milin C; Ferrer L; Faivre-Chauvet A; Campion L; Vuillez JP; Devillers A; Chang CH; Goldenberg DM; Chatal JF; Barbet J
J Nucl Med; 2006 Feb; 47(2):247-55. PubMed ID: 16455630
[TBL] [Abstract][Full Text] [Related]
48. Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
De Santis R; Albertoni C; Petronzelli F; Campo S; D'Alessio V; Rosi A; Anastasi AM; Lindstedt R; Caroni N; Arseni B; Chiodi P; Verdoliva A; Cassani G; Chinol M; Paganelli G; Carminati P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2191-6. PubMed ID: 16609034
[TBL] [Abstract][Full Text] [Related]
49. Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.
Sharkey RM; Karacay H; Vallabhajosula S; McBride WJ; Rossi EA; Chang CH; Goldsmith SJ; Goldenberg DM
Radiology; 2008 Feb; 246(2):497-507. PubMed ID: 18227543
[TBL] [Abstract][Full Text] [Related]
50. The relationship of glycosylation and isoelectric point with tumor accumulation of avidin.
Yao Z; Zhang M; Sakahara H; Nakamoto Y; Higashi T; Zhao S; Sato N; Arano Y; Konishi J
J Nucl Med; 1999 Mar; 40(3):479-83. PubMed ID: 10086714
[TBL] [Abstract][Full Text] [Related]
51. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
Schluep T; Cheng J; Khin KT; Davis ME
Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
[TBL] [Abstract][Full Text] [Related]
53. Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49.
Wittel UA; Jain M; Goel A; Baranowska-Kortylewicz J; Kurizaki T; Chauhan SC; Agrawal DK; Colcher D; Batra SK
Biochem Biophys Res Commun; 2005 Apr; 329(1):168-76. PubMed ID: 15721289
[TBL] [Abstract][Full Text] [Related]
54. A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.
Hayashi H; Asano R; Tsumoto K; Katayose Y; Suzuki M; Unno M; Kodama H; Takemura S; Yoshida H; Makabe K; Imai K; Matsuno S; Kumagai I; Kudo T
Cancer Immunol Immunother; 2004 Jun; 53(6):497-509. PubMed ID: 14648071
[TBL] [Abstract][Full Text] [Related]
55. Tumor-targeting antibody-anticalin fusion proteins for in vivo pretargeting applications.
Steiner M; Gutbrodt K; Krall N; Neri D
Bioconjug Chem; 2013 Feb; 24(2):234-41. PubMed ID: 23350721
[TBL] [Abstract][Full Text] [Related]
56. Disulfide cross-linked Fab-aggregates: preparation and biodistribution.
Dalkara S; Petrov A; Trubetskoy VS; Khaw BA; Torchilin VP
J Drug Target; 1998; 6(1):45-52. PubMed ID: 9769020
[TBL] [Abstract][Full Text] [Related]
57. Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting.
Goldenberg DM; Rossi EA; Sharkey RM; McBride WJ; Chang CH
J Nucl Med; 2008 Jan; 49(1):158-63. PubMed ID: 18077530
[TBL] [Abstract][Full Text] [Related]
58. Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris.
FitzGerald K; Holliger P; Winter G
Protein Eng; 1997 Oct; 10(10):1221-5. PubMed ID: 9488147
[TBL] [Abstract][Full Text] [Related]
59. Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibody.
Orcutt KD; Rhoden JJ; Ruiz-Yi B; Frangioni JV; Wittrup KD
Mol Cancer Ther; 2012 Jun; 11(6):1365-72. PubMed ID: 22491799
[TBL] [Abstract][Full Text] [Related]
60. Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.
Chang CH; Sharkey RM; Rossi EA; Karacay H; McBride W; Hansen HJ; Chatal JF; Barbet J; Goldenberg DM
Mol Cancer Ther; 2002 May; 1(7):553-63. PubMed ID: 12479274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
